Table I.
Anthropometric and clinical characteristics of participants
Parameter | Diabetic subjects | Control subjects |
---|---|---|
N (male/female) | 82 (38/44) | 42 (18/24) |
Age [years] | 59.73 ±5.58 | 57.37 ±5.51 |
Disease duration [years] | 11.01 ±5.13 | – |
BMI [kg/m2] | 30.23 ±4.51 | 27.75 ±3.91* |
SBP [mm Hg] | 140.00 ±14.00 | 122.00 ±11.00*** |
DBP [mm Hg] | 80.50 ±9.11 | 76.50 ±8.50 |
CRP [mg/l] | 10.38 ±9.41 | 4.4 ±3.49*** |
WBC [× 109/l] | 7.64 ±4.91 | 7.05 ±1.75*** |
Glucose [mmol/l] | 8.93 ±2.91 | 5.00 ±0.72*** |
HbA1c (%) | 7.8 ±1.54 | 5.67 ±0.27*** |
Total-Ch [mmol/l] | 5.08 ±1.07 | 5.19 ±2.36* |
HDL-Ch [mmol/l] | 1.16 ±0.29 | 1.45 ±0.38** |
LDL-Ch [mmol/l] | 2.95 ±0.85 | 2.95 ±0.61 |
TG [mmol/l] | 2.34 ±0.81 | 1.56 ±0.38*** |
Smoking (%) | 10 | 12 |
Data are presented as mean ± standard deviation or number/percent, statistical significance
p < 0.5
p < 0.01
p < 0.001
BMI – body mass index, SBP – systolic blood pressure, DBP – diastolic blood pressure, CRP – C-reactive protein, WBC – white blood cells, HbA1c – glycated hemoglobin, total-Ch – total cholesterol, HDL-Ch – HDL cholesterol, LDL-Ch – LDL cholesterol, TG – triglyceride.